Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

After three years of unprecedented tech spending and nonstop hype, the demand for AI in the workplace seems to be drying up fast. Looking at the big picture doesn’t make it any prettier. Back in March ...

If only they were robotic! Instead, chatbots have developed a distinctive — and grating — voice. Credit...Illustration by Giacomo Gambineri Supported by By Sam Kriss In the quiet hum of our digital ...

Losing your phone can leave you in panic mode, especially when the battery dies. The good news is that both Apple and Android offer built-in tools that help you track a missing device even when it is ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

GARDEN CITY, Long Island (WABC) -- A college student on Long Island says he was wrongly accused of using artificial intelligence to write an essay, and now he's suing his university. Adelphi ...

I used to believe I taught the one genre that artificial intelligence couldn’t touch. For 15 years, I’ve guided college students through the deeply human work of personal narrative, helping them ...

There was a time when your landline phone would ring and you automatically answered without knowing who was calling. Today, the introduction of cell phones, voicemail, and caller ID has allowed us to ...

Community driven content discussing all aspects of software development from DevOps to design patterns. All you need to do is open an online editor and code away! Which is exactly what we’re going to ...

For this week’s Open Questions column, Dhruv Khullar is filling in for Joshua Rothman. When David Fajgenbaum was a twenty-five-year-old medical student, at the University of Pennsylvania, he started ...